Transanal Local Excision of Rectal Cancer after Neoadjuvant Chemoradiation: Is There a Place for It or Should Be Avoided at All Costs?

 

 Buy Article Permissions and Reprints

Abstract

Tumor response to neoadjuvant chemoradiation (nCRT) with tumor downsizing and downstaging has significantly impacted the number of patients considered to be appropriate candidates for transanal local excision (TLE). Some patients may harbor small residual lesions, restricted to the bowel wall. These patients, who exhibit major response (“near-complete”) by digital rectal examination, endoscopic assessment, and radiological assessment may be considered for this approach. Although TLE is associated with minimal postoperative morbidity, a few clinical consequences and oncological outcomes must be evaluated in advance and with caution. In the setting of nCRT, a higher risk for clinically relevant wound dehiscences leading to a considerable risk for readmission for pain management has been observed. Worse anorectal function (still better than after total mesorectal excision [TME]), worsening in the quality of TME specimen, and higher rates of abdominal resections (in cases requiring completion TME) have been reported. The exuberant scar observed in the area of TLE also represents a challenging finding during follow-up of these patients. Local excision should be probably restricted for patients with primary tumors located at or below the level of the anorectal ring (magnetic resonance defined). These patients are otherwise candidates for abdominal perineal resections or ultra-low anterior resections with coloanal anastomosis frequently requiring definitive stomas or considerably poor anorectal function.

Publication History

Article published online:
28 February 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

• References

• 1 Banerjee AK, Jehle EC, Shorthouse AJ, Buess G. Local excision of rectal tumours. Br J Surg 1995; 82 (09) 1165-1173
  CrossrefPubMedGoogle Scholar
• 2 Halverson AL, Morris AM, Cleary RK, Chang GJ. For patients with early rectal cancer, does local excision have an impact on recurrence, survival, and quality of life relative to radical resection?. Ann Surg Oncol 2019; 26 (08) 2497-2506
  CrossrefPubMedGoogle Scholar
• 3 Menahem B, Alves A, Morello R, Lubrano J. Should the rectal defect be closed following transanal local excision of rectal tumors? A systematic review and meta-analysis. Tech Coloproctol 2017; 21 (12) 929-936
  CrossrefPubMedGoogle Scholar
• 4 Landmann RG, Wong WD, Hoepfl J. et al. Limitations of early rectal cancer nodal staging may explain failure after local excision. Dis Colon Rectum 2007; 50 (10) 1520-1525
  CrossrefPubMedGoogle Scholar
• 5 Saraste D, Gunnarsson U, Janson M. Predicting lymph node metastases in early rectal cancer. Eur J Cancer 2013; 49 (05) 1104-1108
  CrossrefPubMedGoogle Scholar
• 6 Nash GM, Weiser MR, Guillem JG. et al. Long-term survival after transanal excision of T1 rectal cancer. Dis Colon Rectum 2009; 52 (04) 577-582
  CrossrefPubMedGoogle Scholar
• 7 Greenberg JA, Shibata D, Herndon II JE, Steele Jr GD, Mayer R, Bleday R. Local excision of distal rectal cancer: an update of cancer and leukemia group B 8984. Dis Colon Rectum 2008; 51 (08) 1185-1191 , discussion 1191–1194
  CrossrefPubMedGoogle Scholar
• 8 Garcia-Aguilar J, Mellgren A, Sirivongs P, Buie D, Madoff RD, Rothenberger DA. Local excision of rectal cancer without adjuvant therapy: a word of caution. Ann Surg 2000; 231 (03) 345-351
  CrossrefPubMedGoogle Scholar
• 9 Nascimbeni R, Nivatvongs S, Larson DR, Burgart LJ. Long-term survival after local excision for T1 carcinoma of the rectum. Dis Colon Rectum 2004; 47 (11) 1773-1779
  CrossrefPubMedGoogle Scholar
• 10 Nascimbeni R, Burgart LJ, Nivatvongs S, Larson DR. Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum 2002; 45 (02) 200-206
  CrossrefPubMedGoogle Scholar
• 11 Habr-Gama A, Perez RO, Kiss DR. et al. Preoperative chemoradiation therapy for low rectal cancer. Impact on downstaging and sphincter-saving operations. Hepatogastroenterology 2004; 51 (60) 1703-1707
  PubMedGoogle Scholar
• 12 Smith FM, Waldron D, Winter DC. Rectum-conserving surgery in the era of chemoradiotherapy. Br J Surg 2010; 97 (12) 1752-1764
  CrossrefPubMedGoogle Scholar
• 13 Engelen SM, Beets-Tan RG, Lahaye MJ. et al. MRI after chemoradiotherapy of rectal cancer: a useful tool to select patients for local excision. Dis Colon Rectum 2010; 53 (07) 979-986
  CrossrefPubMedGoogle Scholar
• 14 Habr-Gama A, São Julião GP, Perez RO. Pitfalls of transanal endoscopic microsurgery for rectal cancer following neoadjuvant chemoradiation therapy. Minim Invasive Ther Allied Technol 2014; 23 (02) 63-69
  CrossrefPubMedGoogle Scholar
• 15 Marks JH, Valsdottir EB, DeNittis A. et al. Transanal endoscopic microsurgery for the treatment of rectal cancer: comparison of wound complication rates with and without neoadjuvant radiation therapy. Surg Endosc 2009; 23 (05) 1081-1087
  CrossrefPubMedGoogle Scholar
• 16 Perez RO, Habr-Gama A, São Julião GP, Proscurshim I, Scanavini Neto A, Gama-Rodrigues J. Transanal endoscopic microsurgery for residual rectal cancer after neoadjuvant chemoradiation therapy is associated with significant immediate pain and hospital readmission rates. Dis Colon Rectum 2011; 54 (05) 545-551
  CrossrefPubMedGoogle Scholar
• 17 Paganini AM, Balla A, Quaresima S, D'Ambrosio G, Bruzzone P, Lezoche E. Tricks to decrease the suture line dehiscence rate during endoluminal loco-regional resection (ELRR) by transanal endoscopic microsurgery (TEM). Surg Endosc 2015; 29 (05) 1045-1050
  CrossrefPubMedGoogle Scholar
• 18 Biviano I, Balla A, Badiali D. et al. Anal function after endoluminal locoregional resection by transanal endoscopic microsurgery and radiotherapy for rectal cancer. Colorectal Dis 2017; 19 (06) O177-O185
  CrossrefPubMedGoogle Scholar
• 19 Marinello FG, Curell A, Tapiolas I, Pellino G, Vallribera F, Espin E. Systematic review of functional outcomes and quality of life after transanal endoscopic microsurgery and transanal minimally invasive surgery: a word of caution. Int J Colorectal Dis 2020; 35 (01) 51-67
  CrossrefPubMedGoogle Scholar
• 20 Habr-Gama A, Lynn PB, Jorge JM. et al. Impact of organ-preserving strategies on anorectal function in patients with distal rectal cancer following neoadjuvant chemoradiation. Dis Colon Rectum 2016; 59 (04) 264-269
  CrossrefPubMedGoogle Scholar
• 21 Rullier E, Rouanet P, Tuech JJ. et al. Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial. Lancet 2017; 390 (10093): 469-479
  CrossrefPubMedGoogle Scholar
• 22 Gagliardi G, Newton TR, Bailey HR. Local excision of rectal cancer followed by radical surgery because of poor prognostic features does not compromise the long term oncologic outcome. Colorectal Dis 2013; 15 (11) e659-e664
  CrossrefPubMedGoogle Scholar
• 23 Bach SP, Hill J, Monson JR. et al; Association of Coloproctology of Great Britain and Ireland Transanal Endoscopic Microsurgery (TEM) Collaboration. A predictive model for local recurrence after transanal endoscopic microsurgery for rectal cancer. Br J Surg 2009; 96 (03) 280-290
  CrossrefPubMedGoogle Scholar
• 24 Perez RO, Habr-Gama A, Proscurshim I. et al. Local excision for ypT2 rectal cancer–much ado about something. J Gastrointest Surg 2007; 11 (11) 1431-1438 , discussion 1438–1440
  CrossrefPubMedGoogle Scholar
• 25 Chang HC, Huang SC, Chen JS. et al. Risk factors for lymph node metastasis in pT1 and pT2 rectal cancer: a single-institute experience in 943 patients and literature review. Ann Surg Oncol 2012; 19 (08) 2477-2484
  CrossrefPubMedGoogle Scholar
• 26 Hompes R, McDonald R, Buskens C. et al; Association of Coloproctology of Great Britain and Ireland Transanal Endoscopic Microsurgery Collaboration. Completion surgery following transanal endoscopic microsurgery: assessment of quality and short- and long-term outcome. Colorectal Dis 2013; 15 (10) e576-e581
  CrossrefPubMedGoogle Scholar
• 27 Nagtegaal ID, van de Velde CJ, van der Worp E, Kapiteijn E, Quirke P, van Krieken JH. Cooperative Clinical Investigators of the Dutch Colorectal Cancer Group. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 2002; 20 (07) 1729-1734
  CrossrefPubMedGoogle Scholar
• 28 Koedam TWA, Veltcamp Helbach M, Penna M. et al. Short-term outcomes of transanal completion total mesorectal excision (cTaTME) for rectal cancer: a case-matched analysis. Surg Endosc 2019; 33 (01) 103-109
  CrossrefPubMedGoogle Scholar
• 29 Morino M, Allaix ME, Arolfo S, Arezzo A. Previous transanal endoscopic microsurgery for rectal cancer represents a risk factor for an increased abdominoperineal resection rate. Surg Endosc 2013; 27 (09) 3315-3321
  CrossrefPubMedGoogle Scholar
• 30 Serra-Aracil X, Galvez Saldaña A, Mora-Lopez LL. et al. Completion surgery in unfavorable rectal cancer after transanal endoscopic microsurgery: does it achieve satisfactory sphincter preservation, quality of total mesorectal excision specimen, and long-term oncological outcomes?. Dis Colon Rectum 2021; 64 (02) 200-208
  CrossrefPubMedGoogle Scholar
• 31 Bujko K, Richter P, Smith FM. et al. Preoperative radiotherapy and local excision of rectal cancer with immediate radical re-operation for poor responders: a prospective multicentre study. Radiother Oncol 2013; 106 (02) 198-205
  CrossrefPubMedGoogle Scholar
• 32 São Julião GP, Ortega CD, Vailati BB. et al. Magnetic resonance imaging following neoadjuvant chemoradiation and transanal endoscopic microsurgery for rectal cancer. Colorectal Dis 2017; 19 (06) O196-O203
  CrossrefPubMedGoogle Scholar
• 33 Ortega CD, Perez RO. Role of magnetic resonance imaging in organ-preserving strategies for the management of patients with rectal cancer. Insights Imaging 2019; 10 (01) 59
  CrossrefPubMedGoogle Scholar
• 34 Perez RO, Habr-Gama A, Lynn PB. et al. Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution. Dis Colon Rectum 2013; 56 (01) 6-13
  CrossrefPubMedGoogle Scholar
• 35 Pucciarelli S, De Paoli A, Guerrieri M. et al. Local excision after preoperative chemoradiotherapy for rectal cancer: results of a multicenter phase II clinical trial. Dis Colon Rectum 2013; 56 (12) 1349-1356
  CrossrefPubMedGoogle Scholar
• 36 Perez RO, Habr-Gama A, São Julião GP. et al. Transanal local excision for distal rectal cancer and incomplete response to neoadjuvant chemoradiation - does baseline staging matter?. Dis Colon Rectum 2014; 57 (11) 1253-1259
  CrossrefPubMedGoogle Scholar
• 37 Verseveld M, de Graaf EJ, Verhoef C. et al; CARTS Study Group. Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery (CARTS study). Br J Surg 2015; 102 (07) 853-860
  CrossrefPubMedGoogle Scholar
• 38 Garcia-Aguilar J, Shi Q, Thomas Jr CR. et al. A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial. Ann Surg Oncol 2012; 19 (02) 384-391
  CrossrefPubMedGoogle Scholar
• 39 Garcia-Aguilar J, Renfro LA, Chow OS. et al. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial. Lancet Oncol 2015; 16 (15) 1537-1546
  CrossrefPubMedGoogle Scholar
• 40 Bach SP, Gilbert A, Brock K. et al; TREC collaborators. Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study. Lancet Gastroenterol Hepatol 2021; 6 (02) 92-105
  CrossrefPubMedGoogle Scholar
• 41 Perez RO, Habr-Gama A, São Julião GP. et al. Transanal endoscopic microsurgery (TEM) following neoadjuvant chemoradiation for rectal cancer: outcomes of salvage resection for local recurrence. Ann Surg Oncol 2016; 23 (04) 1143-1148
  CrossrefPubMedGoogle Scholar
• 42 Ortholan C, Romestaing P, Chapet O, Gerard JP. Correlation in rectal cancer between clinical tumor response after neoadjuvant radiotherapy and sphincter or organ preservation: 10-year results of the Lyon R 96-02 randomized trial. Int J Radiat Oncol Biol Phys 2012; 83 (02) e165-e171
  CrossrefPubMedGoogle Scholar
• 43 Hayden DM, Jakate S, Pinzon MC. et al. Tumor scatter after neoadjuvant therapy for rectal cancer: are we dealing with an invisible margin?. Dis Colon Rectum 2012; 55 (12) 1206-1212
  CrossrefPubMedGoogle Scholar
• 44 Perez RO, Habr-Gama A, Smith FM. et al. Fragmented pattern of tumor regression and lateral intramural spread may influence margin appropriateness after TEM for rectal cancer following neoadjuvant CRT. J Surg Oncol 2014; 109 (08) 853-858
  CrossrefPubMedGoogle Scholar
• 45 Duldulao MP, Lee W, Streja L. et al. Distribution of residual cancer cells in the bowel wall after neoadjuvant chemoradiation in patients with rectal cancer. Dis Colon Rectum 2013; 56 (02) 142-149
  CrossrefPubMedGoogle Scholar
• 46 Smith FM, Ahad A, Perez RO, Marks J, Bujko K, Heald RJ. Local excision techniques for rectal cancer after neoadjuvant chemoradiotherapy: what are we doing?. Dis Colon Rectum 2017; 60 (02) 228-239
  CrossrefPubMedGoogle Scholar
• 47 Rullier E, Vendrely V, Asselineau J. et al. Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial. Lancet Gastroenterol Hepatol 2020; 5 (05) 465-474
  Google Scholar